Editas Medicine Inc. Company Profile
NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.75+0.02 (+0.73%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.75 0.00%
Editas Medicine at a glance
Editas Medicine Inc. (NASDAQ: EDIT) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2016. At a market capitalization of $419.3 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001650664, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Editas Medicine Inc.
- Ticker
- NASDAQ: EDIT
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- United States
- IPO year
- 2016
- Market cap
- $419.27M
- SEC CIK
- 0001650664
Companies similar to Editas Medicine
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EIKNEikon Therapeutics Inc. | 7.54 | +0.40% | $408.40M | vs EDIT |
| AGMBAgomAb Therapeutics NV ADR | 8.80 | -0.45% | $433.38M | vs EDIT |
| ENTXEntera Bio Ltd. | 2.51 | -0.79% | $436.32M | vs EDIT |
| ZURAZura Bio Limited Class A | 4.17 | +5.30% | $399.61M | vs EDIT |
| TECXTectonic Therapeutic Inc. | 22.71 | +1.34% | $443.97M | vs EDIT |
| KYTXKyverna Therapeutics Inc. | 6.17 | +0.16% | $381.57M | vs EDIT |
| FENCFennec Pharmaceuticals Inc. | 10.36 | +0.10% | $363.30M | vs EDIT |
| AUTLAutolus Therapeutics plc ADR | 1.81 | +1.12% | $481.75M | vs EDIT |